| scholarly article | Q13442814 |
| P356 | DOI | 10.1002/HEP.510270237 |
| P953 | full work available online at | https://api.wiley.com/onlinelibrary/tdm/v1/articles/10.1002%2Fhep.510270237 |
| https://journals.lww.com/01515467-199802000-00037 | ||
| https://onlinelibrary.wiley.com/doi/pdfdirect/10.1002/hep.510270237 | ||
| P698 | PubMed publication ID | 9462661 |
| P5875 | ResearchGate publication ID | 227976010 |
| P50 | author | Maria Jose Morán | Q68111391 |
| P2093 | author name string | H. de Verneuil | |
| P. Couzigou | |||
| V. de Ledinghen | |||
| I. Hombrados | |||
| R. E. De Salamanca | |||
| A. Fontanellas | |||
| E. Brudieux | |||
| P2860 | cites work | Biochimica et Biophysica Acta | Q864239 |
| A novel MHC class I-like gene is mutated in patients with hereditary haemochromatosis | Q24310146 | ||
| An inherited enzymatic defect in porphyria cutanea tarda: decreased uroporphyrinogen decarboxylase activity | Q24634032 | ||
| A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding | Q25938984 | ||
| Formulation and application of a numerical scoring system for assessing histological activity in asymptomatic chronic active hepatitis | Q29619627 | ||
| Human immunodeficiency virus infection and porphyria cutanea tarda: coexistence of risk factors or causative association? | Q40520697 | ||
| Familial and sporadic porphyria cutanea: two different diseases | Q41953376 | ||
| Mechanism of iron potentiation of hepatic uroporphyria: studies in cultured chick embryo liver cells | Q42198736 | ||
| Hepatitis C virus and porphyria cutanea tarda: evidence of a strong association | Q42982870 | ||
| Porphyria cutanea tarda and antibodies to hepatitis C virus. | Q43038650 | ||
| HCV infection in porphyria cutanea tarda | Q43038848 | ||
| Hepatitis C virus antibodies and liver disease in patients with porphyria cutanea tarda | Q43815439 | ||
| Immunoreactive uroporphyrinogen decarboxylase in the liver in porphyria cutanea tarda | Q44872150 | ||
| Hepatitis C virus infection and porphyria cutanea tarda in Australasia | Q45772383 | ||
| Is hepatitis C virus infection a trigger of porphyria cutanea tarda? | Q45787026 | ||
| Hepatitis C virus-related autoimmunity in patients with porphyria cutanea tarda | Q45789957 | ||
| The frequency of hemochromatosis-associated alleles is increased in British patients with sporadic porphyria cutanea tarda | Q58227799 | ||
| Effect of alcohol on δ-aminolevulinic acid dehydratase and porphyrin metabolism in man | Q67887767 | ||
| Hepatitis B serum markers in porphyria cutanea tarda | Q68884474 | ||
| Hepatic mitochondrial oxidative metabolism and lipid peroxidation in experimental hexachlorobenzene-induced porphyria with dietary carbonyl iron overload | Q69587860 | ||
| The involvement of iron and lipid peroxidation in the pathogenesis of HCB induced porphyria | Q70048207 | ||
| Changes in protoporphyrin distribution dynamics during liver failure and recovery in a patient with protoporphyria and Epstein-Barr viral hepatitis | Q70139355 | ||
| Decreased hepatic uroporphyrinogen decarboxylase activity in porphyria cutanea tarda | Q70294209 | ||
| The difference in liver pathology between sporadic and familial forms of porphyria cutanea tarda: the role of iron | Q70871968 | ||
| Some kinetic properties of human red cell uroporphyrinogen decarboxylase | Q71128835 | ||
| Genetic polymorphisms of cytochrome P4502E1 related to the development of alcoholic liver disease | Q72718206 | ||
| Hepatitis C in patients with porphyria cutanea tarda | Q72810934 | ||
| Increased frequency of the haemochromatosis Cys282Tyr mutation in sporadic porphyria cutanea tarda | Q73048056 | ||
| Mutations of the hereditary hemochromatosis candidate gene HLA-H in porphyria cutanea tarda | Q73300467 | ||
| P433 | issue | 2 | |
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | porphyria cutanea tarda | Q1479497 |
| P304 | page(s) | 584-589 | |
| P577 | publication date | 1998-02-01 | |
| P1433 | published in | Hepatology | Q15724398 |
| P1476 | title | Hepatic uroporphyrinogen decarboxylase activity in porphyria cutanea tarda patients: the influence of virus C infection | |
| Hepatic uroporphyrinogen decarboxylase activity in porphyria cutanea tarda patients: The influence of virus C infection | |||
| P478 | volume | 27 |
| Q33738759 | Alcohol intake and porphyria cutanea tarda |
| Q62607272 | Autoantibodies to human cytosol: a marker of sporadic porphyria cutanea tarda |
| Q45743545 | Effect of hepatobiliary disease, chronic hepatitis C and hepatitis B virus infections and interferon-alpha on porphyrin profiles in plasma, urine and faeces |
| Q34422768 | Extrahepatic manifestations of infection with hepatitis C virus |
| Q45954724 | Familial porphyria cutanea tarda in Spain: Characterization of eight novel mutations in the UROD gene and haplotype analysis of the common p.G281E mutation |
| Q92046226 | Heme biosynthesis and the porphyrias |
| Q34268811 | Hepatitis C, porphyria cutanea tarda and liver iron: an update |
| Q37831136 | Liver cirrhosis induced by porphyria cutanea tarda: a case report and review |
| Q36114779 | Molecular mechanisms of dominant expression in porphyria |
| Q35045210 | Pancreatic involvement in chronic viral hepatitis |
| Q36267789 | Porphyria Diagnostics-Part 1: A Brief Overview of the Porphyrias |
| Q42988426 | Porphyria cutanea tarda, hepatitis C, and HFE gene mutations in north america† |
| Q34097888 | Porphyria cutanea tarda. |
| Q91227989 | Porphyria cutanea tarda: Recent update |
| Q45713240 | Porphyria cutanea tarda: multiplicity of risk factors including HFE mutations, hepatitis C, and inherited uroporphyrinogen decarboxylase deficiency |
| Q38110514 | Porphyrin and heme metabolism and the porphyrias. |
| Q35217843 | Prevalence of hepatitis C virus infection in porphyria cutanea tarda: systematic review and meta-analysis. |
| Q34027590 | Role of HFE gene mutations in liver diseases other than hereditary hemochromatosis |
| Q34743412 | The cutaneous manifestations of viral hepatitis |
Search more.